Top News
Latest News
INSIGHTS
24 Jan 2026
AbbVie’s RemeGen Bet Highlights a Shift in Cancer StrategyRESEARCH
19 Jan 2026
Pfizer Moves Deeper Into ADCs With Pivotal Lung Cancer TrialsPARTNERSHIPS
14 Jan 2026
In Precision Oncology, Smart Alliances Are Beating Big BuysREGULATORY
8 Jan 2026
Orphan Drug Incentives Shape Next Wave of Cancer Deals
A Small Deal With a Big Message for US Cancer Drugmakers
INVESTMENT
14 Nov 2025
Day One’s Mersana buy shows how US drugmakers are moving earlier to lock up promising antibody-drug conjugates
INSIGHTS
24 Jan 2026
AbbVie’s RemeGen Bet Highlights a Shift in Cancer Strategy
AbbVie’s RC148 deal with RemeGen reflects a broader push to combine ADCs with complementary drugs for longer lasting cancer responses
RESEARCH
19 Jan 2026
Pfizer Moves Deeper Into ADCs With Pivotal Lung Cancer Trials
Pfizer advances an investigational ADC into Phase III lung cancer trials, testing monotherapy and combination approaches amid rising compe...
PARTNERSHIPS
14 Jan 2026
In Precision Oncology, Smart Alliances Are Beating Big Buys
Lilly’s stake in Aktis’s planned IPO shows how oncology partnerships are reshaping innovation by blending science, capital, and caution
REGULATORY
8 Jan 2026
Orphan Drug Incentives Shape Next Wave of Cancer Deals
US orphan drug incentives are quietly steering ADC development and deal-making, nudging firms toward rare cancers as precision oncology ac...
INVESTMENT
14 Nov 2025
A Small Deal With a Big Message for US Cancer Drugmakers
Day One’s Mersana buy shows how US drugmakers are moving earlier to lock up promising antibody-drug conjugates
TECHNOLOGY
5 Nov 2025
AI May Be the Missing Link in ADC Cancer Precision
AI-guided tissue analysis is sharpening patient selection, cutting trial risk, and speeding more precise ADC cancer drug development
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.